Neuland Laboratories has announced a Board of Directors meeting scheduled for February 9, 2026. The meeting aims to approve and record the unaudited financial results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. The trading window for company shares remains closed until 48 hours after the results are declared.
Board Meeting Details
A meeting of the Board of Directors at Neuland Laboratories is scheduled for February 9, 2026. The primary agenda is to review and approve the unaudited financial results of the company.
Financial Results on the Agenda
The board will consider the unaudited financial results (Standalone and Consolidated) for the quarter and nine months ending December 31, 2025. The approved results will provide insights into the company’s performance.
Trading Window Closure
The trading window for dealing in the company’s equity shares remains closed and will reopen 48 hours after the declaration of the unaudited financial results. This closure, effective from January 1, 2026, ensures compliance with Insider Trading regulations.
Source: BSE
